Auto Accidents
    Dangerous Drugs
    Defective Medical Devices
    Defective Products
    Dog Bite Injuries
    Food Poisoning
    Lead Poisoning
    Medical Malpractice
    Nursing Home Cases
    Slip and Fall Accidents
    Social Security Disability
    Workers Compensation
    Wrongful Death
    Asbestos/Mesothelioma
    Beryllium
    Boating Accidents
    Construction Accidents
    Clergy Misconduct
    Immigration
    Job Discrimination
    Liquor Liability
    Sexual Harrassment
    Toxic Mold
    

 

 

 


Permax

Get a free Permax case evaluation<<<<<<<

Permax (pergolide mesylate)
The side effects of Permax have caused serious medical complications in some patients and have most recently been linked to heart valve damage.

Breaking News:
The U.S. Food and Drug Administration announced March 29, 2007 that Permax as well as two generic versions of Pergolide were being voluntarily withdrawn from the market. The withdrawal follows on the heels of two recent New England Journal of Medicine articles confirming previous findings associating the drugs with increased risk of heart valve damage.

What is Permax?
Permax is a drug used in the treatment of Parkinson’s disease and restless leg syndrome. Parkinson’s disease is a progressive neurological disorder caused by the degeneration of nerve cells in the movement centers of the brain. The degeneration of the nerve cells results in a decreased level of the chemical dopamine. A lack of dopamine results in problems with bodily movement, causing the tremors that characterizes the disease. Permax is prescribed to increase the level of dopamine in the body.

Permax is often used in combination with the drug Levodopa, which is the most common treatment for Parkinson’s.


What you should be aware of:
Permax was introduced to the market in 1989. In 2003 the U.S. Food and Drug Administration (FDA) required that Eli Lily, the manufacturer of Permax, modify the package insert to warn of the risk of heart valve damage or cardiac valvulopathy.

In January 2007 results of an Italian study were published supporting the FDA’s 2003 warning. Italian researchers found one quarter of Parkinson’s patients taking Permax, had moderate to severe heart valve problems. A separate German study found that users of Permax were 5 to 7 times more likely to experience heart valve damage than those on other types of Parkinson’ drugs. Both studies were published in the New England Journal of Medicine on January 3, 2007.

Doctors at the Mayo Clinic described details of the heart valve damage caused by Permax in a report. This report identifies three women ages 61, 72 and 74 that had been using Permax, in various doses, for 3-7 years, for treatment of Parkinson’s. Each woman was diagnosed with heart valve damage. None of the women had a prior history of heart disease. Two of the women required valve replacement surgery. Following this discovery, doctors reviewed their surgical records to determine if other patients undergoing heart valve replacement surgery had a history of using Permax. Doctors found one out of seventeen patients had used Permax.

Contact us:
If you or a loved one has been injured due to the use of Permax, you need a Permax attorney familiar with new developments in the investigation of Permax to help you make important personal and legal decisions, and if needed to file a lawsuit. Contact us now to get the help you deserve. Give us a call at 800-992-6878 or CLICK HERE for a free case evaluation.


Last Updated 3/14/07